Fingerprint
Dive into the research topics of 'Methylene Blue for Treatment of Hospitalized COVID-19 Patients, Randomized, Controlled, Open-Label Clinical Trial, Phase 3'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Methylene Blue for Treatment of Hospitalized COVID-19 Patients, Randomized, Controlled, Open-Label Clinical Trial, Phase 3
Daryoush Hamidi Alamdari* (Corresponding Author), Saied Hafizi Lotfabadi, Behzad Mavaji Darban, Marzieh Agheli-Rad, Shahin Saadatian, Seyed Hadi Hashemi, Fatemeh Barazandeh Ahmadabadi, Negar Morovatdar, Mohammad Arastoo, Bharat Bhushan
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
32
Downloads
(Pure)